查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1965960

非處方口服避孕藥市場－全球產業規模、佔有率、趨勢、機會和預測：按藥片類型、類別、分銷管道、地區和競爭格局分類，2021-2031年

Over the Counter Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Pill Type, By Category, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球非處方口服避孕藥市場預計將從 2025 年的 179 億美元大幅成長至 2031 年的 297.6 億美元，複合年成長率為 8.84%。

這些非處方藥通常只含黃體素，消費者無需醫生處方箋即可獲得荷爾蒙避孕藥。這些藥片透過增稠子宮頸黏液來阻止精子進入並抑制排卵，為生殖健康管理提供了一種便捷的方法。推動這一市場發展的主要因素是全球法規結構的轉變，該轉變允許從處方藥過渡到非處方藥，從而增強了消費者的自主權並減輕了醫療機構的後勤負擔。這種可近性提高的趨勢正在支撐全球需求的成長，世界衛生組織（WHO）的數據顯示，到2024年，全球77.1%的育齡婦女將使用現代方法滿足其計劃生育需求，這便是最好的證明。

市場概覽
預測期 2027-2031
市場規模：2025年 179億美元
市場規模：2031年 297.6億美元
複合年成長率：2026-2031年 8.84%
成長最快的細分市場 複方片劑
最大的市場 北美洲

儘管存在這些積極因素，但市場仍面臨一個重大障礙：非處方藥的保險報銷不一致。消費者需要自付部分費用，這可能會讓對價格敏感的消費者望而卻步，尤其是在醫療補貼取決於是否有正式處方箋的地區。因此，即使產品供應充足，此經濟障礙也會限制低收入族群的市場滲透率，並阻礙市場進一步擴張。

市場促進因素

越來越多的監管機構核准將處方藥轉換為非處方藥（OTC），這正在改變市場格局，因為這樣就無需醫生介入購買過程。這種監管轉變使得製造商能夠直接向消費者提供孕激素單藥療法，從而提高用戶便利性並減輕醫療保健系統的負擔。這種商業性效應在新核准產品的策略定價中得到了清晰的體現，旨在促進大眾市場接受度。例如，該公司在2024年3月發布的新聞稿中宣布，其在美國推出的首個非處方口服避孕藥「Opil」的建議零售價為19.99美元（一個月用量）。這是該公司在獲得FDA核准後旨在促進產品普及的策略。

此外，電子商務和線上藥局通路的擴張是重要的次要促進因素，監管方面的進步確保了實體和數位管道的廣泛普及。透過將銷售融入主流零售環境，市場正在克服傳統的物流和隱私障礙。這個廣泛的分銷網路在滿足全球計劃生育需求方面發揮著至關重要的作用。聯合國人口基金（UNFPA）估計，到2024年，購買的避孕藥具將預防約1,800萬例意外懷孕。公共衛生模型也反映了這一分銷管道的成長規模。英國衛生與社會保障部確認，英格蘭已有3,000家藥局完成註冊，可直接向民眾供應口服避孕藥，如《藥學雜誌》2024年1月刊所述。

市場挑戰

非處方口服避孕藥市場商業性成長的主要障礙之一是缺乏穩定的健保報銷機制。隨著這些產品從處方箋藥轉變為非處方箋藥，第三方支付方的報銷往往消失，將全部經濟負擔轉嫁到購買者身上。這種成本負擔的轉移構成了一項直接的經濟障礙，限制了價格敏感族群的接受度。儘管監管政策的調整改善了購買管道，但需要自費購買使得那些先前依賴全額補貼處方藥的潛在用戶猶豫不決。

這種報銷差異導致市場分散，使製造商無法全面了解市場需求。由於各州的保險覆蓋要求各不相同，產品的可及性往往更多地取決於地理位置而非醫療需求。凱撒家庭基金會2024年的報告凸顯了這個問題，報告顯示，美國祇有七個州立法強制要求州監管的私人醫療保險計劃涵蓋非處方箋避孕藥。這項數據表明，這些產品的資金支持基礎分散，直接限制了市場滲透率，並在立法框架未能跟上產品供應速度的地區抑制了收入成長。

市場趨勢

訂閱式補貨模式的興起正在從根本上改變消費行為，將購買習慣從一次性交易轉變為持續互動。這種模式透過自動化補貨解決了維持口服避孕藥使用的關鍵挑戰，並降低了意外停藥的可能性，同時確保了製造商的長期客戶維繫。透過將產品與自動化配送和虛擬助理結合，這些服務避免了傳統藥房取藥帶來的許多不便，並吸引了重視隱私和便利的消費者。消費者健康平台的擴張證明了這個策略的成功。根據 Investing.com 2025 年 11 月的報告，Hims & Hers Health 的個人化訂閱服務用戶已達到約 250 萬，年成長 21%。

同時，用於合格篩檢的行動醫療應用程式的引入，正在建立一個先進的數位基礎設施，從而實現安全獲取非處方藥。與傳統的電子商務網站不同，這些應用程式使用演算法調查問卷即時確定禁忌症，並模擬臨床分診流程，無需面對面諮詢。這種數位化柔軟性使得企業能夠在維持醫療安全標準的同時，快速回應市場需求波動。 Femtech Insider 在 2025 年 1 月報告的一個案例凸顯了這種技術主導方法的敏捷性：遠端醫療提供者 Wisp 在一次關鍵的政治變革發生前一周，事後緊急避孕藥的銷售環比激增 233%，這凸顯了數位篩檢平台在實現即時市場進入發揮的關鍵作用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球非處方口服避孕藥市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 避孕藥類型（黃體素片、複方片）
    • 按類別（非專利、品牌商品）
    • 分銷通路（線下、線上）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美非處方口服避孕藥市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲非處方口服避孕藥市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區非處方口服避孕藥市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲非處方口服避孕藥市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲非處方口服避孕藥市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球非處方口服避孕藥市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Mylan NV
  • Nurx Inc.
  • Everly Well, Inc.
  • Letsgetchecked Inc.
  • Uqora, Inc.
  • Hims & Hers Health, Inc.
  • Lemonaid Health, Inc.
  • Perrigo Company plc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23813

The Global Over the Counter (OTC) Contraceptive Pills Market is projected to expand significantly, rising from USD 17.90 Billion in 2025 to USD 29.76 Billion by 2031, reflecting a CAGR of 8.84%. These over-the-counter medications, generally comprising progestin-only formulations, allow consumers to obtain hormonal contraception without a prescription from a healthcare provider. By thickening cervical mucus to impede sperm and suppressing ovulation, these pills provide a streamlined method for managing reproductive health. A primary catalyst for this market is the global shift in regulatory frameworks enabling Rx-to-OTC switches, which enhances consumer autonomy and alleviates logistical pressures on clinical facilities. This trend toward greater accessibility supports growing global demand, evidenced by World Health Organization data from 2024 showing that 77.1% of women of reproductive age worldwide had their family planning needs met through modern methods.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 17.90 Billion
Market Size 2031USD 29.76 Billion
CAGR 2026-20318.84%
Fastest Growing SegmentCombination Pills
Largest MarketNorth America

Despite these positive drivers, the market faces a substantial obstacle regarding the inconsistent insurance reimbursement for non-prescription drugs. The necessity of covering out-of-pocket expenses can discourage price-sensitive buyers, particularly in regions where healthcare subsidies depend on having a formal prescription. Consequently, this financial barrier restricts market penetration among lower-income demographics, impeding broader expansion despite the availability of the products.

Market Driver

The increasing number of regulatory approvals for Prescription-to-OTC switches is transforming the market by eliminating the need for physician intervention in the purchasing process. This regulatory shift encourages manufacturers to introduce progestin-only options directly to consumers, thereby simplifying the user journey and lessening the demand on medical systems. The commercial effect is visible in the strategic pricing of these newly approved products, which targets mass-market adoption. For instance, Perrigo Company plc announced in a March 2024 press release regarding 'Opill First Over-The-Counter Birth Control In The U.S.' that the suggested retail price for a one-month supply was set at $19.99, a strategy aimed at encouraging widespread use following the FDA's approval.

Furthermore, the expansion of e-commerce and online pharmacy channels acts as a crucial secondary driver, ensuring these regulatory advancements result in broad physical and digital availability. By incorporating sales into mainstream retail environments, the market overcomes previous logistical and privacy-related obstacles. This extensive distribution network plays a key role in fulfilling global family planning requirements; the United Nations Population Fund estimated in 2024 that procured contraceptives averted approximately 18 million unintended pregnancies. The magnitude of this channel growth is also evident in public health models, as highlighted by Pharmacy Magazine in January 2024, which noted the Department of Health and Social Care's confirmation that 3,000 pharmacies in England had registered to supply oral contraception directly to the public.

Market Challenge

A significant impediment to the commercial growth of the over-the-counter contraceptive pills market is the absence of consistent insurance reimbursement for non-prescription medications. When these products move from prescription-only status to retail shelves, third-party payer coverage frequently disappears, transferring the full financial responsibility to the buyer. This shift in cost establishes an immediate economic hurdle that restricts adoption among price-sensitive groups. Even with improved physical access due to regulatory changes, the necessity for point-of-sale out-of-pocket payments discourages potential users who previously depended on fully subsidized prescription alternatives.

This gap in reimbursement causes market fragmentation and hinders manufacturers from capturing the full extent of demand. Because coverage mandates vary, accessibility often depends on geographic location rather than medical necessity. Highlighting this issue, the Kaiser Family Foundation reported in 2024 that only seven U.S. states had enacted laws requiring state-regulated private health insurance plans to cover over-the-counter contraception without a prescription. This statistic emphasizes the fragmented financial support landscape for these products, which directly limits market penetration and suppresses revenue growth in regions where legislative frameworks have not kept pace with product availability.

Market Trends

The rise of subscription-based replenishment models is fundamentally changing consumer behavior by transitioning purchasing habits from one-off transactions to recurring engagements. This approach tackles the vital challenge of adherence to oral contraception by automating refills, thereby reducing the chance of unintended usage gaps and ensuring long-term customer retention for manufacturers. By combining products with automated delivery and virtual assistance, these services circumvent the logistical inconveniences of traditional pharmacy visits, appealing to consumers who value privacy and convenience. The success of this strategy is demonstrated by the expansion of direct-to-consumer health platforms; as reported by Investing.com in November 2025, Hims & Hers Health saw its subscriber base for personalized recurring treatments increase by 21% year-over-year to approximately 2.5 million users.

Simultaneously, the incorporation of mobile health applications for eligibility screening is establishing a sophisticated digital framework that facilitates safe over-the-counter access. Unlike conventional e-commerce sites, these applications employ algorithmic questionnaires to instantly identify contraindications, mimicking the clinical triage process without the need for a physical medical appointment. This digital flexibility enables the market to quickly adapt to shifts in public demand while maintaining medical safety standards. The agility of this technology-driven method was underscored when Femtech Insider reported in January 2025 that telehealth provider Wisp saw a 233% week-over-week surge in emergency contraception sales prior to significant political transitions, illustrating the vital function of digital screening platforms in enabling immediate market access.

Key Market Players

  • Mylan N.V.
  • Nurx Inc.
  • Everly Well, Inc.
  • Letsgetchecked Inc.
  • Uqora, Inc.
  • Hims & Hers Health, Inc.
  • Lemonaid Health, Inc.
  • Perrigo Company plc

Report Scope

In this report, the Global Over the Counter (OTC) Contraceptive Pills Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Over the Counter (OTC) Contraceptive Pills Market, By Pill Type

  • Progestin Pills
  • Combination Pills

Over the Counter (OTC) Contraceptive Pills Market, By Category

  • Generic
  • Branded

Over the Counter (OTC) Contraceptive Pills Market, By Distribution Channel

  • Offline
  • Online

Over the Counter (OTC) Contraceptive Pills Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Over the Counter (OTC) Contraceptive Pills Market.

Available Customizations:

Global Over the Counter (OTC) Contraceptive Pills Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Pill Type (Progestin Pills, Combination Pills)
    • 5.2.2. By Category (Generic, Branded)
    • 5.2.3. By Distribution Channel (Offline, Online)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Pill Type
    • 6.2.2. By Category
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Pill Type
        • 6.3.1.2.2. By Category
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Pill Type
        • 6.3.2.2.2. By Category
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Pill Type
        • 6.3.3.2.2. By Category
        • 6.3.3.2.3. By Distribution Channel

7. Europe Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Pill Type
    • 7.2.2. By Category
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Pill Type
        • 7.3.1.2.2. By Category
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Pill Type
        • 7.3.2.2.2. By Category
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Pill Type
        • 7.3.3.2.2. By Category
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Pill Type
        • 7.3.4.2.2. By Category
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Pill Type
        • 7.3.5.2.2. By Category
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Pill Type
    • 8.2.2. By Category
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Pill Type
        • 8.3.1.2.2. By Category
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Pill Type
        • 8.3.2.2.2. By Category
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Pill Type
        • 8.3.3.2.2. By Category
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Pill Type
        • 8.3.4.2.2. By Category
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Pill Type
        • 8.3.5.2.2. By Category
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Pill Type
    • 9.2.2. By Category
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Pill Type
        • 9.3.1.2.2. By Category
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Pill Type
        • 9.3.2.2.2. By Category
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Pill Type
        • 9.3.3.2.2. By Category
        • 9.3.3.2.3. By Distribution Channel

10. South America Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Pill Type
    • 10.2.2. By Category
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Pill Type
        • 10.3.1.2.2. By Category
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Pill Type
        • 10.3.2.2.2. By Category
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Pill Type
        • 10.3.3.2.2. By Category
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Over the Counter (OTC) Contraceptive Pills Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Mylan N.V.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Nurx Inc.
  • 15.3. Everly Well, Inc.
  • 15.4. Letsgetchecked Inc.
  • 15.5. Uqora, Inc.
  • 15.6. Hims & Hers Health, Inc.
  • 15.7. Lemonaid Health, Inc.
  • 15.8. Perrigo Company plc

16. Strategic Recommendations

17. About Us & Disclaimer